ClinicalTrials.gov
ClinicalTrials.gov Menu

Can Resistance Enhance Selection of Treatment? (CREST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00262717
Recruitment Status : Completed
First Posted : December 7, 2005
Last Update Posted : June 9, 2006
Sponsor:
Collaborators:
Abbott
Boehringer Ingelheim
GlaxoSmithKline
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Roche Pharma AG
Virco
Diagnostic Technology
Perkin Elmer Inc.
Information provided by:
Kirby Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : August 2002